Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansChemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stressProteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal AdenocarcinomaSpectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Proteomic Approaches for Biomarker Panels in Cancer.Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Proteins Differentially Expressed in the Pancreas of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice Fed Ethanol For 3 Months.Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
P2860
Q21710680-7EAA7773-7428-487F-B5D3-717DDDB8AC63Q33777591-85E90FA8-4218-4B6F-86F3-F7FDECDFC095Q34797866-A0B5F518-A294-419E-822F-FBE5328D05A4Q36367896-8497E358-8A05-4CA9-90BD-A22A497287FAQ36408948-F56C2BC6-0579-485C-BCE6-96346E12C3B4Q36512558-42A2F525-1646-4727-AAF1-66266A409AFDQ37651691-1E4A7D70-B2EC-4F91-81AE-1308EC45DA1EQ37714579-AE7E926E-D890-4AD3-98E5-B9ED25604489Q38604366-EDCA7854-6309-4CDE-9A08-72856EB11EBFQ38632577-4AE9B975-C122-4A44-ABD1-E50C5DD5480AQ38761444-E83751BD-B439-4C72-BB4D-E1827FAB7607Q39389689-6F7EADA5-3154-4AA0-B5B8-353D43DF199DQ41334598-41929AA1-7B59-4F57-9BAC-3C7376097967Q46573931-C5C5F69B-7022-46C4-BB8B-BB291DCBFB7BQ47659096-160F3B12-1EAC-489A-B55E-EE488456EED7Q52148219-67B06D6C-DC6C-4AFF-868E-E4EACCEDDCFB
P2860
Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Proteomic identification of po ...... creatic ductal adenocarcinoma.
@en
Proteomic identification of po ...... creatic ductal adenocarcinoma.
@nl
type
label
Proteomic identification of po ...... creatic ductal adenocarcinoma.
@en
Proteomic identification of po ...... creatic ductal adenocarcinoma.
@nl
prefLabel
Proteomic identification of po ...... creatic ductal adenocarcinoma.
@en
Proteomic identification of po ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Proteomic identification of po ...... ncreatic ductal adenocarcinoma
@en
P2093
Andrada Seicean
Praveen K Sappa
Rareş Buiga
P2860
P304
P356
10.1002/PMIC.201300402
P577
2014-03-03T00:00:00Z